subject area of
- A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma Academic Article
- A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma Academic Article
- A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191 Academic Article
- A phase II study of ZD6474 (Zactima™), a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma—NCIC CTG IND.145 Academic Article
- A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7 Academic Article
- A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial Academic Article
- A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients Academic Article
- Acute renal failure in multiple myeloma. Academic Article
- Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 study Academic Article
- Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma Academic Article
- Antigen Interaction and Heat Inactivation Expose New Epitopes on Human IgE Academic Article
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents Academic Article
- Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study Academic Article
- Assessment of observer variation in measuring the radiographic vertebral index in patients with multiple myeloma Academic Article
- Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma Conference Paper
- Autologous stem cell transplant in older patients (age ≥ 65) with newly diagnosed multiple myeloma: A systematic review and meta-analysis Academic Article
- Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age Academic Article
- Bortezomib in Multiple Myeloma: A Practice Guideline Academic Article
- Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma Academic Article
- COMPARISON OF FRAILTY SCORES IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA: A REVIEW Academic Article
- Canadian Perspective on Managing Multiple Myeloma during the COVID-19 Pandemic: Lessons Learned and Future Considerations Academic Article
- Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma Academic Article
-
Che‐1‐induced inhibition of
mTOR pathway enables stress‐induced autophagy Academic Article - Clinical Utility of Biochemical Markers of Bone Metabolism for Improving the Management of Patients with Advanced Multiple Myeloma Academic Article
- Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma Academic Article
- DMG26 Academic Article
- Daratumumab in newly diagnosed MM — incorporating lessons learnt from CASSIOPEIA, MAIA and beyond Academic Article
- Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells Academic Article
- Development of a B-cell maturation antigen-specific T-cell antigen coupler receptor for multiple myeloma Academic Article
- Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma Academic Article
- Disparities in treatment patterns and outcomes among younger and older adults with newly diagnosed multiple myeloma: A population-based study Academic Article
- Diversity and Diversification of Light Chains in Myeloma:The Specter of Amyloidogenesis by Proxy Academic Article
- Donor leukocyte infusions for multiple myeloma Academic Article
- Effect of Awareness of a Randomized Controlled Trial on Use of Experimental Therapy Academic Article
- Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance. Academic Article
- Expression of Retrovirally Transduced IL-1 α in IL-6-Dependent B Cells: A Murine Model of Aggressive Multiple Myeloma Academic Article
- External validation of the FIRST trial’s simplified frailty score in a population-based cohort Academic Article
- Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials Academic Article
- Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis Academic Article
- Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment Academic Article
- Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies Conference Paper
- Hypercoagulability in Multiple Myeloma and Its Precursor State, Monoclonal Gammopathy of Undetermined Significance Academic Article
- INDEPENDENT CLONAL ORIGIN OF COEXISTING CHRONIC LYMPHOCYTIC LEUKAEMIA AND MULTIPLE MYELOMA Academic Article
- Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients Academic Article
- Intra-articular solitary fibrous tumor of the knee Academic Article
- Just the facts: how to diagnose and manage patients with multiple myeloma in the emergency department? Academic Article
- Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial Academic Article
- Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells Academic Article
- Low‐depth sequencing for copy number abnormalities in multiple myeloma supersedes fluorescent in situ hybridization in scope and resolution Academic Article
- Lymphoma with hypercalcemia. Academic Article
- Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis Academic Article
- Maintenance therapy in transplant ineligible adults with newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis Academic Article
- Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials Group. Academic Article
- Multiple Myeloma Mortality in Relation to Obesity Among African Americans Academic Article
- Novel Treatments for Multiple Myeloma: What Role Do They Have in Older Adults? Academic Article
- Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34+ absolute counts and subsets Academic Article
- Oral bisphosphonates Academic Article
- Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma Academic Article
- Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database Academic Article
- Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study Academic Article
- Phase II study of subcutaneous rHu-interleukin-2 and rHu-interferon α-2a in previously treated patients with multiple myeloma Academic Article
- Plasma Exchange When Myeloma Presents as Acute Renal Failure Academic Article
- Plasma exchange for myeloma kidney: cast(s) away? Academic Article
- Production of hybrid cell lines secreting antibodies to herpes simplex virus type 2 Academic Article
- Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy Academic Article
-
Quality of
end‐of‐life care in multiple myeloma: A13‐year analysis of a population‐based cohort in Ontario, Canada Academic Article - Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma. Academic Article
- Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group. Academic Article
- Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database Academic Article
- Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world” Academic Article
- Results of a Multicenter Randomized Phase II Trial of Thalidomide and Prednisone Maintenance Therapy for Multiple Myeloma after Autologous Stem Cell Transplant Academic Article
- Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era Academic Article
- Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin Academic Article
- Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database Academic Article
- Simplified frailty assessment tools: are we really capturing frailty or something else? Academic Article
- Spectrum of imaging findings in abdominal extraosseous myeloma Academic Article
- Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database Academic Article
- Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study Academic Article
- Teclistamab in Relapsed or Refractory Multiple Myeloma Academic Article
- Thalidomide-prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10 Academic Article
- The Evolving Field of Bone Imaging in Multiple Myeloma: Is it Time to Abandon Skeletal Surveys? Academic Article
- The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors Academic Article
- The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative Academic Article
- The relationship of CD34+ dosage and platelet recovery following high dose chemotherapy and autologous CD34+ reinfusion in multiple myeloma Academic Article
- The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review Academic Article
- The value of elevated gamma globulins in the diagnosis of monoclonal gammopathy and multiple myeloma Academic Article
- Thrombosis is associated with inferior survival in multiple myeloma Academic Article
- Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper Academic Article
- Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline Academic Article
- Vesicular Stomatitis Virus: A Potential Therapeutic Virus for the Treatment of Hematologic Malignancy Academic Article
- Vitritis and retinal vasculitis as presenting signs of monoclonal gammopathy of unknown significance with progression to multiple myeloma Academic Article
- Weekly Cyclophosphamide and Alternate-Day Prednisone: An Effective, Convenient, and Well-Tolerated Oral Treatment for Relapsed Multiple Myeloma After Autologous Stem Cell Transplantation Academic Article
- Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma. Academic Article
- Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity. Academic Article